NEW YORK (GenomeWeb News) – BG Medicine announced today a public offering of units comprising its common stock and warrants that is expected to bring in net proceeds of $2.1 million.

The Waltham, Massachusetts-based firm is offering 2,315,654 Series A units each consisting of one share of common stock and one half of a warrant to purchase one share of common stock at $1 per Series A unit.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.